507 related articles for article (PubMed ID: 6331647)
1. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture.
Fitzpatrick SL; LaChance MP; Schultz GS
Cancer Res; 1984 Aug; 44(8):3442-7. PubMed ID: 6331647
[TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture.
Imai Y; Leung CK; Friesen HG; Shiu RP
Cancer Res; 1982 Nov; 42(11):4394-8. PubMed ID: 6290036
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor levels.
Fitzpatrick SL; Brightwell J; Wittliff JL; Barrows GH; Schultz GS
Cancer Res; 1984 Aug; 44(8):3448-53. PubMed ID: 6331648
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
Koga M; Musgrove EA; Sutherland RL
Cancer Res; 1990 Aug; 50(16):4849-55. PubMed ID: 2379149
[TBL] [Abstract][Full Text] [Related]
5. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells.
Koga M; Eisman JA; Sutherland RL
Cancer Res; 1988 May; 48(10):2734-9. PubMed ID: 2834048
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor binding and protein kinase C activities in human breast cancer cell lines: possible quantitative relationship.
Fabbro D; Küng W; Roos W; Regazzi R; Eppenberger U
Cancer Res; 1986 Jun; 46(6):2720-5. PubMed ID: 3008998
[TBL] [Abstract][Full Text] [Related]
7. EGF receptors in R3230AC rat mammary carcinomas: characteristics and regulation in vitro and in vivo.
Ryan PD; Hilf R
Oncol Res; 1992; 4(4-5):181-92. PubMed ID: 1504378
[TBL] [Abstract][Full Text] [Related]
8. Effect of epidermal growth factor on the proliferation of human epithelial cancer cell lines: correlation with the level of occupied EGF receptor.
Dong XF; Berthois Y; Martin PM
Anticancer Res; 1991; 11(2):737-43. PubMed ID: 2064328
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factors type beta 1 and beta 2 are equipotent growth inhibitors of human breast cancer cell lines.
Zugmaier G; Ennis BW; Deschauer B; Katz D; Knabbe C; Wilding G; Daly P; Lippman ME; Dickson RB
J Cell Physiol; 1989 Nov; 141(2):353-61. PubMed ID: 2808542
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor alpha-Pseudomonas exotoxin 40 fusion protein.
Arteaga CL; Hurd SD; Dugger TC; Winnier AR; Robertson JB
Cancer Res; 1994 Sep; 54(17):4703-9. PubMed ID: 8062268
[TBL] [Abstract][Full Text] [Related]
11. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells.
Murphy LJ; Sutherland RL; Stead B; Murphy LC; Lazarus L
Cancer Res; 1986 Feb; 46(2):728-34. PubMed ID: 3000583
[TBL] [Abstract][Full Text] [Related]
12. Presence of transforming growth factors in human breast cancer cells.
Salomon DS; Zwiebel JA; Bano M; Losonczy I; Fehnel P; Kidwell WR
Cancer Res; 1984 Sep; 44(9):4069-77. PubMed ID: 6331663
[TBL] [Abstract][Full Text] [Related]
13. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid.
Kosano H; Takatani O
Cancer Res; 1988 Nov; 48(21):6033-6. PubMed ID: 3262419
[TBL] [Abstract][Full Text] [Related]
14. Modulation of epidermal growth factor receptors by gamma interferon in a breast cancer cell line.
Chakravarthy A; Chen LC; Mehta D; Hamburger AW
Anticancer Res; 1991; 11(1):347-51. PubMed ID: 1902074
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
Uckun FM; Narla RK; Jun X; Zeren T; Venkatachalam T; Waddick KG; Rostostev A; Myers DE
Clin Cancer Res; 1998 Apr; 4(4):901-12. PubMed ID: 9563884
[TBL] [Abstract][Full Text] [Related]
16. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells.
Sartor CI; Dziubinski ML; Yu CL; Jove R; Ethier SP
Cancer Res; 1997 Mar; 57(5):978-87. PubMed ID: 9041204
[TBL] [Abstract][Full Text] [Related]
17. The effects of epidermal growth factor on cell proliferation and prolactin production by GH3 rat pituitary cells.
Yajima Y; Saito T
J Cell Physiol; 1984 Aug; 120(2):249-56. PubMed ID: 6086677
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines.
Mohamood AS; Gyles P; Balan KV; Hollis VW; Eckberg WR; Asseffa A; Han Z; Wyche JH; Anderson WA
J Submicrosc Cytol Pathol; 1997 Jan; 29(1):1-17. PubMed ID: 9066137
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
Toi M; Bicknell R; Harris AL
Cancer Res; 1992 Jan; 52(2):275-9. PubMed ID: 1728401
[TBL] [Abstract][Full Text] [Related]
20. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.
Furlanetto RW; DiCarlo JN
Cancer Res; 1984 May; 44(5):2122-8. PubMed ID: 6324997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]